30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study

KimberlyVanover; StevenGlass; SusanKozauer; JelenaSaillard; JuanSanchez; MichalWeingart; SharonMates; AndrewSatlin; RobertDavis

首页> 外文期刊>CNS spectrums >30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study

【24h】

30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study

机译：30 LumatePerone（ITI-007）用于治疗精神分裂症：安慰剂控制临床试验概述和开放式安全切换研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《CNS spectrums》 |2019年第1期|共2页
作者
KimberlyVanover; StevenGlass; SusanKozauer; JelenaSaillard; JuanSanchez; MichalWeingart; SharonMates; AndrewSatlin; RobertDavis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. 30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study [J] . KimberlyVanover, StevenGlass, SusanKozauer, CNS spectrums . 2019,第1期

机译：30 LumatePerone（ITI-007）用于治疗精神分裂症：安慰剂控制临床试验概述和开放式安全切换研究
2. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia A Randomized Clinical Trial [J] . Correll Christoph U., Davis Robert E., Weingart Michal, JAMA psychiatry . 2020,第4期

机译：Lumateperone治疗精神分裂症A随机临床试验的疗效和安全性
3. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial (vol 13, pg 512, 2020) [J] . Correll C. U., Davis R. E., Weingart M. JAMA psychiatry . 2020,第4期

机译：Lumateperone治疗精神分裂症的疗效和安全性：随机临床试验（Vol 13，PG 512,2020）
4. Soft tissue injuries upon sport activities and traffic accidents-treatment with low-level laser therapy: a multicenter, duble-blind; placebo-controlled clinical study on 132 patients [C] . Zlatko Simunovic, Tatjana Trobonjaca Conference on Laser Florence'99: A Window on the Laser Medicine World 28-31 October 1999 Florence, Italy . 1999

机译：体育活动和交通事故中的软组织损伤-低水平激光治疗：多中心，双盲；安慰剂对照的132例临床研究
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. S44. LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY [O] . Kimberly Vanover, Alex Dmitrienko, Steven Glass, 2018

机译：S44。 LUMATEPERONE（ITI-007）用于治疗精神分裂症：局部控制的临床试验和开式安全开关研究
7. F46. LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA [O] . Robert Davis, Alex Dmitrienko, Steven Glass, 2018

机译：F46。 LumatePerone（ITI-007）：从精神分裂症患者的护理标准抗精神病药疗法的开放标签安全切换研究中有利的安全性。

30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study

著录项

相似文献

相关主题

期刊订阅